Related Experiment Videos
Dissolution properties of different designed and formulated salbutamol tablet dosage forms
1Gulhane Military Medical Academy, Department of Pharmaceutical Technology, 06018 Etlik, Ankara, Turkey.
Acta Poloniae Pharmaceutica
|December 29, 2000
Summary
Dissolution testing of salbutamol tablets revealed fast drug release from commercial formulations. The Zero-Order (RRSBW) kinetic model best described the observed dissolution rates for these antiasthmatic drug products.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery
- Pharmacokinetics
Background:
- Pharmaceutical availability is crucial for drug efficacy.
- Dissolution testing provides key insights into drug product performance.
- Salbutamol is a widely used antiasthmatic medication.
Purpose of the Study:
- To evaluate the dissolution profiles of various salbutamol tablet formulations.
- To compare dissolution testing methods for pharmaceutical quality control.
- To determine the best-fit kinetic model for salbutamol tablet dissolution.
Main Methods:
- Dissolution tests were conducted using the paddle and rotating basket methods (USP).
- Three distinct salbutamol tablet formulations marketed in Turkey were analyzed.
- Five different kinetic models were applied to evaluate dissolution rates.
Main Results:
- All tested salbutamol formulations met pharmacopeial requirements.
- Commercial salbutamol tablets demonstrated rapid drug release.
- Some formulations exhibited slower drug release characteristics.
- The RRSBW (Zero-Order) kinetic model provided the best fit for dissolution data.
Conclusions:
- Dissolution testing is a valuable tool for assessing salbutamol drug product quality.
- Commercial salbutamol tablets are formulated for rapid release.
- The RRSBW model accurately describes the dissolution behavior of these formulations.